Arkema S.A. (OTCMKTS:ARKAY - Get Free Report) was the recipient of a large growth in short interest in April. As of April 15th, there was short interest totalling 4,500 shares, a growth of 1,025.0% from the March 31st total of 400 shares. Based on an average daily trading volume, of 80,400 shares, the days-to-cover ratio is presently 0.1 days. Approximately 0.0% of the shares of the stock are sold short.
Arkema Price Performance
Arkema stock traded up $0.32 during midday trading on Monday, reaching $75.75. The company had a trading volume of 13,051 shares, compared to its average volume of 16,952. The company has a market capitalization of $5.76 billion, a P/E ratio of 15.15, a P/E/G ratio of 0.53 and a beta of 1.18. Arkema has a 12-month low of $64.94 and a 12-month high of $111.13. The firm's fifty day simple moving average is $78.82 and its 200-day simple moving average is $80.20. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.11 and a quick ratio of 1.54.
Analyst Ratings Changes
Separately, Sanford C. Bernstein began coverage on shares of Arkema in a research note on Thursday. They issued an "underperform" rating on the stock.
Get Our Latest Research Report on Arkema
Arkema Company Profile
(
Get Free Report)
Arkema SA manufactures and sells specialty chemicals and advanced materials worldwide. The company operates in three segments: Adhesive Solutions, Advanced Materials and Coating Solutions, and Intermediates. The Adhesive Solutions segment provides solutions for construction, renovation of buildings, DIY, durable goods, and packaging and non-woven applications; and supplies technologies used in building activities for businesses and individuals, including sealants, tiles, flooring adhesives and waterproofing systems, and technologies used in industry, which include automotive, textiles, glazing, flexible and rigid packaging, and hygiene markets.
Recommended Stories
Before you consider Arkema, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arkema wasn't on the list.
While Arkema currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.